Healthequity (HQY) Receivables (2014 - 2026)

Healthequity has reported Receivables for 13 years, with the latest figure at $123.7 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 4.82% year-over-year to $123.7 million; the trailing twelve-month figure through Jan 2026 stood at $123.7 million (up 4.82% YoY), and the FY2026 full-year result was $123.7 million, up 4.82% from the prior year.
• Receivables for Q1 2026 stood at $123.7 million, up from $111.2 million in the prior quarter.
• The five-year high for Receivables was $123.7 million in Q1 2026, with the low at $86.0 million in Q2 2022.
• Average Receivables over 5 years is $102.5 million, with a median of $104.9 million recorded in 2024.
• Year-over-year, Receivables rose 21.83% in 2022 and gained 2.38% in 2023.
• Tracing HQY's Receivables over 5 years: stood at $87.7 million in 2022, then gained by 9.65% to $96.2 million in 2023, then advanced by 10.95% to $106.7 million in 2024, then gained by 4.25% to $111.2 million in 2025, then advanced by 11.19% to $123.7 million in 2026.
• The last three Receivables figures came in at $123.7 million (Q1 2026), $111.2 million (Q4 2025), and $111.2 million (Q3 2025), per Business Quant data.

Peer Comparison